Rossari Biotech (NSE:ROSSARI) Other Current Payables: ₹201 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ROSSARI Rossari Biotech Ltd NSE:ROSSARI
85 GF Score
Price ₹535.75
GF Value ₹1,005.31
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Rossari Biotech Other Current Payables?

Rossari Biotech NSE:ROSSARI +1.57% 85 Other Current Payables is ₹201 Mil as of Mar. 2026. GuruFocus rates NSE:ROSSARI with a GF Score™ of 85/100 and a GF Value™ of ₹1,005.31 (Possible Value Trap). The stock has 4 warning signs investors should review.

Rossari Biotech's Other Current Payables for the quarter that ended in Mar. 2026 was ₹201 Mil.

Rossari Biotech's quarterly Other Current Payables stayed the same from Sep. 2025 (₹0 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹201 Mil).

Rossari Biotech's annual Other Current Payables increased from Mar. 2024 (₹57 Mil) to Mar. 2025 (₹173 Mil) and increased from Mar. 2025 (₹173 Mil) to Mar. 2026 (₹201 Mil).

Rossari Biotech Other Current Payables Related Terms

Rossari Biotech Other Current Payables Historical Data

* Premium members only.

The historical data trend for Rossari Biotech's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rossari Biotech Other Current Payables Chart

Rossari Biotech Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Payables
Get a 7-Day Free Trial Premium Member Only 86.98 104.31 57.40 173.47 200.98

Rossari Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 173.47 0.00 0.00 0.00 200.98
NSE:ROSSARI
85GF Score
Rossari Biotech Ltd NSE:ROSSARI
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rossari Biotech Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of ₹201 Mil mean?
Rossari Biotech (NSE:ROSSARI) has a Other Current Payables of ₹201 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Rossari Biotech and its competitors.
Is Rossari Biotech's Other Current Payables too high?
Rossari Biotech's current Other Current Payables is ₹201 Mil. Overall, Rossari Biotech has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossari Biotech's Other Current Payables compare to LIN and SHW?
Rossari Biotech's Other Current Payables of ₹201 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Chemicals company?
A good Other Current Payables depends on the Chemicals industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Rossari Biotech and its competitors. Rossari Biotech's current Other Current Payables is ₹201 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossari Biotech stock overvalued right now?
Based on GuruFocus' analysis, Rossari Biotech (NSE:ROSSARI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹1,005.31, compared to a current price of ₹535.75 — trading 46.7% below its estimated fair value. The current Other Current Payables is ₹201 Mil. Rossari Biotech's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Rossari Biotech (NSE:ROSSARI), the current Other Current Payables is ₹201 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rossari Biotech (NSE:ROSSARI) Overvalued in 2026?

Based on GuruFocus' analysis, Rossari Biotech stock appears to be undervalued. The current stock price of ₹535.75 is trading 46.7% below its estimated GF Value™ of ₹1,005.31. GuruFocus considers Rossari Biotech to be Possible Value Trap.

Key valuation signals for NSE:ROSSARI:

  • Other Current Payables: ₹201 Mil
  • GF Value™: ₹1,005.31 vs. price of ₹535.75 (46.7% below fair value)
  • GF Score™: 85/100 with 4 warning signs

No single metric tells the full story. See the NSE:ROSSARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rossari Biotech Business Description

Other Exchanges 543213:India
Address Rossari House, Lal Bahadur Shastri Marg, Golden Oak, Opp. Mahindra Showroom, Vikhroli (West), Surya Nagar, Mumbai, MH, IND, 400079
Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry, and animal feed industries through its product portfolio comprising home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories: home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals, pulp and paper, and cleaning chemical formulations, among others. The company generates the majority revenue from India.
85GF Score

Get the complete analysis for NSE:ROSSARI

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹535.75
Price
₹1,005.31
GF Value